New Delhi: Covid-19 mRNA vaccines may increase risk of heart-related deaths, Florida Surgeon General Dr. Joseph A Ladapo said on Saturday. In recommending against the use of the Covid mRNA vaccine, Dr. Lepado said an analysis of Jab’s increased risk has been made public.Also Read – What companies are doing to help employees cope with mental challenges
“Today, we released an analysis of the COVID-19 mRNA vaccines that people need to be aware of. The analysis found an increased risk of cardiac-related death among men aged 18-39. FL will not remain silent on the truth,” Dr Lepado said, as reported by news agency ANI. Also Read – See Covid, flu infection cases spike – what are the symptoms and how to differentiate
The Florida Department of Health (Department) conducted the analysis through self-controlled case series, a technique originally developed to assess vaccine safety. This mRNA studies the risk of death after Covid-19 vaccination. Also Read – Air pollution is likely to increase the severity of Covid, even for vaccination, study finds
COVID mRNA vaccines: Who is most at risk?
According to research, Dr. Ladapo said it increased the risk of cardiac-related death among men between the ages of 18-39. The analysis found an 84 percent increase in the relative incidence of cardiac-related death among men aged 18-39 in the 28 days following the mRNA vaccination, read the Florida Health advisory signed by Florida Governor Ron DeSantis and LaDapo.
He further advised individuals with pre-existing cardiac conditions such as myocarditis and pericarditis to exercise special caution and discuss with their healthcare provider when considering vaccination.
What about non-mRNA vaccines?
With high levels of global immunity against Covid-19, the benefit of vaccination is likely to outweigh the disproportionately high risk of cardiac-related death among men in this age group. Read the Florida Department of Health Bulletin.
Surgeon General Dr. “Studying the safety and efficacy of any drug, including vaccines, is an important component of public health,” said Joseph Ladapo.
“Safety has received too little attention and the concerns of many individuals have been dismissed – these are important findings that should be communicated to Floridians,” Ladapo added.
What are mRNA covid vaccines?
As the Covid-19 pandemic unfolded, an mRNA vaccine candidate was the first to enter human trials globally. The first two vaccines that were made available for use in the US were based on mRNA technology.
Unlike vaccines that put a weakened or inactive virus into your body to activate an immune response, these two COVID-19 vaccines (Pfizer-Biontech and Moderna) use messenger RNA, or mRNA, to deliver a message to your immune system.
Basically, the technology uses genetically engineered mRNA to instruct cells to make the S-protein found on the surface of the Covid virus. According to reports from the US-based Mayo Clinic, after vaccination, muscle cells begin to produce S-protein fragments and display them on the cell surface. This causes the body to make antibodies.
India’s 1st mRNA COVID vaccine to be available soon
India’s first mRNA Covid-19 vaccine is likely to be available soon. The Drugs Controller General of India (DCGI) is expected to grant emergency use authorization for Genova’s mRNA vaccine soon.
The company has conducted Phase 2 and Phase 3 data trials on 4000 participants to assess the safety, immunogenicity and tolerability of the vaccine.
The vaccine – GEMCOVAC-19 – is the country’s first indigenous mRNA COVID-19 vaccine.
According to Genova officials, trial data showed the vaccine was safe and well tolerated. Immunogenicity measured at 2 weeks post-dose showed that GEMCOVAC-19 was non-inferior to Covishield. Two doses of the vaccine are to be administered intramuscularly, 28 days apart.
(with inputs from ANI)
